Is it safe to take nonsteroidal anti-inflammatory drugs (NSAIDs) after cataract surgery?

Can You Take NSAIDs After Cataract Surgery?

Yes, NSAIDs are not only safe but actively recommended after cataract surgery—they are superior to corticosteroids alone for preventing cystoid macular edema (CME) and are routinely used as part of standard postoperative care. 1, 2, 3

Evidence-Based Recommendation

The most recent ophthalmology guidelines explicitly recommend topical NSAIDs for postoperative management after cataract surgery. The 2024 Taiwan Society of Cataract and Refractive Surgeons consensus and the 2023 Refractive Surgery Preferred Practice Pattern both state that preservative-free topical NSAIDs are recommended for use within the first post-surgical month for inflammation control and CME prophylaxis 2, 1.

Why NSAIDs Are Recommended

For CME Prevention:

• High-quality evidence demonstrates NSAIDs significantly reduce CME risk compared to corticosteroids alone (3.8% vs 25.3%, risk ratio 5.35) 4
• The protective effect is substantial: NSAIDs reduce CME incidence by 74% when used alone versus corticosteroids 5
• A 2023 study showed topical NSAIDs (bromfenac) resulted in only 0.4% CME incidence versus 3.9% with corticosteroid inserts 6

For Inflammation Control:

• NSAIDs are as effective as corticosteroids for controlling anterior chamber inflammation 7, 5
• They provide superior control of conjunctival hyperemia and less corneal thickness increase 7
• Patients report lower ocular discomfort with NSAIDs versus steroids 7

Optimal Regimen

Standard approach:

• Use topical NSAIDs (bromfenac, nepafenac, or diclofenac) starting immediately postoperatively
• Continue for the first month after surgery
• Preservative-free formulations are preferred to minimize ocular surface toxicity 2

Combination therapy is even better:

• NSAIDs plus corticosteroids together provide superior CME prevention compared to corticosteroids alone 8, 5
• This combination approach is supported by multiple guidelines 1, 2

Important Safety Considerations

Rare but serious corneal complications: The 2023 Refractive Surgery guidelines note that "significant corneal reactions, including epithelial defects and stromal ulceration and melting, are rare complications of topical ocular NSAID use" 1. However, these events are exceedingly uncommon and should not deter appropriate use.

When to exercise caution:

• Patients with pre-existing dry eye disease should receive preservative-free formulations 2
• Monitor for epithelial toxicity in high-risk patients 2
• Avoid in patients with known NSAID hypersensitivity 9

Specific Drug Choices

Based on comparative effectiveness data:

• Diclofenac shows the best overall efficacy for inflammation control 10
• Nepafenac is most effective for pain relief 10
• Bromfenac demonstrates excellent CME prevention with twice-daily dosing 7, 6

All three are appropriate choices; selection depends on availability and patient-specific factors.

Clinical Algorithm

For routine, uncomplicated cataract surgery:

1. Start topical NSAID (bromfenac 0.075% twice daily OR nepafenac 0.1% three times daily) immediately postoperatively
2. Continue for 4 weeks minimum
3. Use preservative-free formulation if available
4. Combine with topical corticosteroid for optimal inflammation control 1, 2

For high-risk patients (diabetics, prior CME, uveitis history):

1. Mandatory NSAID use—not optional 3
2. Consider extending duration beyond 4 weeks
3. Monitor closely for CME development at 1 week, 2 weeks, and 1 month 2

Common Pitfall to Avoid

Do not rely on corticosteroids alone for postoperative management. The evidence is clear that this approach results in 5-fold higher CME rates compared to including NSAIDs in the regimen 4. The 2022 Cataract PPP explicitly states that "topical NSAIDs reduce the incidence of early postoperative cystoid macular edema" 3.

Bottom line: NSAIDs after cataract surgery are not just safe—they are standard of care and should be used routinely unless specifically contraindicated.